Skip to content
  • Clinical Studies
  • Schedule M
  • Stability Studies
  • Pharma GMP
  • Pharma Tips
  • Pharma Books
  • Pharma Validation
  • Pharma Regulatory

SOP Guide for Pharma

The Ultimate Resource for Pharmaceutical SOPs and Best Practices

  • Home
  • Job Safety Analysis (JSA)
    • Oral Dosage Forms (Tablets & Capsules)
    • Oral Liquid Dosage Forms (Syrups, Elixirs, Suspensions, Emulsions)
    • Powder and Granule Dosage Forms
    • Topical Dosage Forms (Creams, Ointments, Gels, Lotions, Pastes)
    • Transdermal Dosage Forms (Patches)
  • Standard Test Procedures (STP)
  • SOP – Blog Post
  • Toggle search form

API Manufacturing: SOP for Trending of IPC Results and Deviations – V 2.0

Posted on By

API Manufacturing: SOP for Trending of IPC Results and Deviations – V 2.0

Standard Operating Procedure for Trending of IPC Results and Deviations in API Manufacturing

Department API Manufacturing
SOP No. SOP/API/111/2025
Supersedes SOP/API/111/2022
Page No. Page 1 of 10
Issue Date 13/04/2025
Effective Date 15/04/2025
Review Date 13/04/2026

1. Purpose

To define a standardized procedure for trending In-Process Control (IPC) test results and related deviations in API manufacturing to monitor process stability, detect patterns, and facilitate continual improvement and CAPA (Corrective and Preventive Action) implementation.

2. Scope

This SOP applies to all IPC results generated during batch processing of APIs and intermediates, and any documented

deviations identified at various manufacturing stages, covering parameters like pH, LOD, assay, yield, and temperature control.

3. Responsibilities

  • QA Officer: Compile IPC data monthly, perform trend analysis, identify outliers or emerging trends, and generate reports.
  • QC Analyst: Submit IPC data in standardized format; support analysis with raw data when required.
  • Production Supervisor: Provide context for trends/deviations observed and assist in root cause analysis.
See also  API Manufacturing: SOP for Sieve Integrity Verification - V 2.0

4. Accountability

The QA Head is accountable for ensuring data trending is conducted as per this SOP and that significant findings are escalated for appropriate action.

5. Procedure

5.1 IPC Data Compilation

  1. QA shall collect IPC results from all batches completed during the review period (monthly/quarterly).
  2. Parameters to be trended include but are not limited to:
    • pH
    • Loss on Drying (LOD)
    • Reaction Completion Time
    • Process Yield
    • Drying Temperature
  3. Enter the data in the IPC Trending Template (Annexure-1) in a spreadsheet or validated software system.

5.2 Trending Methodology

  1. Calculate the following for each parameter:
    • Mean
    • Standard Deviation (SD)
    • Control Limits (±3 SD)
    • Specification Limits (as per MFR/QC Specs)
  2. Use line charts or control charts to visually represent data trends batch-wise.
  3. Highlight any values falling outside alert or action limits.
See also  API Manufacturing: SOP for Color and Odor Assessment in Intermediates - V 2.0

5.3 Analysis of Deviations

  1. Review all IPC-related deviations during the review period from the Deviation Register.
  2. Categorize deviations as:
    • Out-of-Specification (OOS)
    • Out-of-Trend (OOT)
    • Operational Deviations
  3. Summarize the deviation frequency and common root causes in the IPC Trend Report (Annexure-2).

5.4 Corrective and Preventive Action (CAPA)

  1. If repetitive deviations or negative trends are observed:
    • Initiate CAPA as per the Quality System
    • Assign timeline, responsible personnel, and verification method
  2. QA shall track implementation and effectiveness review of CAPA within 30 days.

5.5 Reporting and Escalation

  1. QA shall issue a monthly or quarterly IPC Trending Report summarizing:
    • Summary of parameter trends
    • Deviations identified
    • CAPAs initiated
    • Recommendations (if any)
  2. Share the report with Production, QC, and Management for review and follow-up.

6. Abbreviations

  • IPC: In-Process Control
  • SOP: Standard Operating Procedure
  • QA: Quality Assurance
  • QC: Quality Control
  • CAPA: Corrective and Preventive Action
  • OOT: Out of Trend
  • OOS: Out of Specification

See also  API Manufacturing: SOP for Testing of Reaction Completion by TLC - V 2.0

7. Documents

  1. IPC Trending Template (Annexure-1)
  2. IPC Trend Summary Report (Annexure-2)
  3. Deviation Register

8. References

  • ICH Q10 – Pharmaceutical Quality System
  • ICH Q9 – Quality Risk Management
  • WHO TRS 986 – GMP Guidelines
  • 21 CFR Part 211 – cGMP for Finished Pharmaceuticals

9. SOP Version

Version: 2.0

10. Approval Section

Prepared By Checked By Approved By
Signature
Date
Name
Designation
Department

11. Annexures

Annexure-1: IPC Trending Template

Batch No. Date Parameter Result Mean Control Limits Remarks
API-20250413 13/04/2025 pH 6.8 6.7 6.4–7.0 Within limits

Annexure-2: IPC Trend Summary Report

Month Total Batches Deviations OOS OOT CAPA Initiated Remarks
April 2025 12 2 0 1 Yes OOT for LOD trend noted

Revision History:

Revision Date Revision No. Details Reason Approved By
01/01/2022 1.0 Initial SOP Issue Compliance Requirement QA Head
13/04/2025 2.0 Incorporated CAPA tracking and deviation categorization Audit Improvement QA Head
API Manufacturing V 2.0 Tags:API batch record, API BMR, API calibration, API centrifuge, API cleaning, API crystallization, API deviation, API documentation, API drying, API equipment cleaning, API filtration, API GMP compliance, API granulation, API hold time, API impurities, API line clearance, API manufacturing, API process, API quality control, API reactor, API sampling, API solvent handling, API validation, API waste disposal, API yield

Post navigation

Previous Post: Analytical Method Development: Specific Gravity & Density Determination Method – V 2.0

Standard Operating Procedures V 1.0

  • Aerosols
  • Analytical Method Development
  • Bioequivalence Bioavailability Study
  • Capsule Formulation
  • Clinical Studies
  • Creams
  • Data Integrity
  • Dental Dosage Forms
  • Drug Discovery
  • Environment, Health and Safety
  • Formulation Development
  • Gels
  • Good Distribution Practice
  • Good Warehousing Practices
  • In-Process Control
  • Injectables
  • Liquid Orals
  • Liposome and Emulsion Formulations
  • Lotions
  • Lyophilized Products
  • Maintenance Dept.
  • Medical Devices
  • Metered-Dose Inhaler
  • Microbiology Testing
  • Nanoparticle Formulation
  • Nasal Spray Formulations
  • Nebulizers
  • Ocular (Eye) Dosage Forms
  • Ointments
  • Otic (Ear) Dosage Forms
  • Pharmacovigilance
  • Powder & Granules
  • Purchase Departments
  • Quality Assurance
  • Quality Control
  • Raw Material Stores
  • Regulatory Affairs
  • Tablet Manufacturing
  • Rectal Dosage Forms
  • Transdermal Patches
  • Vaginal Dosage Forms
  • Validations and Qualifications

Read SOPs in your Language:

 - 
Bengali
 - 
bn
English
 - 
en
Gujarati
 - 
gu
Hindi
 - 
hi
Malayalam
 - 
ml
Marathi
 - 
mr
Punjabi
 - 
pa
Tamil
 - 
ta
Telugu
 - 
te

NEW! Revised SOPs – V 2.0

  • Aerosols V 2.0
  • Analytical Method Development V 2.0
  • API Manufacturing V 2.0
  • BA-BE Studies V 2.0
  • Biosimilars V 2.0
  • Capsules V 2.0
  • Creams V 2.0
  • Elixers V 2.0
  • Ointments V 2.0
  • Raw Material Warehouse V 2.0
  • Tablet Manufacturing V2.0

New Publication: A must for All.

Copyright © 2025 SOP Guide for Pharma.

Powered by PressBook WordPress theme

Go to mobile version